Jesús Montero
About
In The Last Decade
Jesús Montero
14 papers receiving 154 citations
Peers
Comparison fields: 5 of 33
- Public Health, Environmental and Occupational Health 128
- Ophthalmology 64
- Radiology, Nuclear Medicine and Imaging 63
- Immunology and Allergy 55
- Dermatology 21
Countries citing papers authored by Jesús Montero
This map shows the geographic impact of Jesús Montero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jesús Montero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jesús Montero more than expected).
Fields of papers citing papers by Jesús Montero
This network shows the impact of papers produced by Jesús Montero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jesús Montero. The network helps show where Jesús Montero may publish in the future.
Co-authorship network of co-authors of Jesús Montero
This figure shows the co-authorship network connecting the top 25 collaborators of Jesús Montero. A scholar is included among the top collaborators of Jesús Montero based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jesús Montero. Jesús Montero is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 12 | |
| 2 | 10 | |
| 3 | 7 | |
| 4 | Corneal sensitivity repeatability with a new non-contact air jet corneal esthesiometer and comparison with Cochet-Bonnet esthesiometer. | 3 |
| 5 | Safety and Tolerability of Topical Cyclosporine A Cationic Emulsion in Patients With Active Severe Vernal Keratoconjunctivitis (VKC) in Pediatric Patients: Pooled Results of the NOVATIVE and VEKTIS Trials | 1 |
| 6 | 27 | |
| 7 | 16 | |
| 8 | 73 | |
| 9 | Topical Ciclosporin A 1 mg/mL Cationic Emulsion in the Treatment of Active Severe Vernal Keratoconjunctivitis (VKC) in Pediatric Patients: Results of the Phase III VEKTIS Study | 1 |
| 10 | 1 | |
| 11 | 1 | |
| 12 | 3 | |
| 13 | [Effectiveness and impact in the quality of life of ketotifen ophthalmic solution. Results of zeta study in patients with seasonal allergic conjunctivitis]. | 1 |
| 14 | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.